The Institute for Exposomic Research is the nucleus of the Icahn School of Medicine at Mount Sinai’s research on environmental exposures and their impact on human health. With our trandisciplinary research program, expertise, and analytical capabilities, we are designing innovative exposure measures and studying a vast array of diseases, from childhood diseases like autism and ADHD to those conditions experienced later in life such as Alzheimer’s disease and Lou Gehrig’s disease.  

It is a particularly exciting time for environmental health at Mount Sinai with the opening of the Laboratory for Innovation in Exposomic Precision Medicine in 2020. The new laboratory complements the work in the Senator Frank R. Lautenberg Environmental Health Sciences Laboratory, the Physiological Assessment of Children’s Environmental Risk (PACER) Laboratory, and the Environmental Nephrotoxicology Laboratory.